Solid Biosciences Inc.
Solid Biosciences Inc. engages in developing therapies for duchenne muscular dystrophy in the United States. The company's lead product candidate is SGT-001, a gene transfer candidate, which is in a Phase I/II clinical trial to drive functional dystrophi…
Biotechnology
US, Cambridge [HQ]
Value per Employee (VpE) · Surveys · Talents
Employees Analysis
Value per Employee (VpE) · Surveys · Talents
Employee Surveys
Employees Asked: -No survey available at the moment.